COMMUNIQUÉS West-GlobeNewswire

Alpha Bites: Reviews, Ingredients, Studies and Where to Buy
05/02/2025
LAKELAND, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Alpha Bites also known as “AlphaBites“ arrives at a pivotal moment when countless men, facing declining stamina and confidence, seek innovative ways to recapture the [...]
Lipozem – Reviews, Ingredients, Study Findings and Where to Buy
05/02/2025
LAKELAND, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Lipozem which must not be confused with Lipozene, arrives at a time when many people, worn out by strict diets, stalled weight loss, and temporary results, want a more [...]
Accumulus Synergy assure la diffusion simultanée du premier dossier réglementaire numérique du secteur dans près de 25 pays
05/02/2025
BURLINGAME, Calif., 05 févr. 2025 (GLOBE NEWSWIRE) -- Dans un moment décisif pour le secteur, Accumulus Synergy (« Accumulus ») a permis à Amgen de présenter un dossier réglementaire révolutionnaire : le tout premier [...]
Interim report 2024/25 - Solid H1 performance driven by growth in both revenue and earnings
05/02/2025
ANNOUNCEMENT NO. 287 5 February 2025 Solid H1 performance driven by growth in both revenue and earnings Martin Helbo Behrens, CEO: The growth continued in the second quarter of 2024/25, and revenue for the first half of [...]
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time
05/02/2025
EDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Alcott Joins Screenland 5K: Run for a Cause
05/02/2025
CULVER CITY, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Alcott joins Screenland 5k Run/Walk as one of this year’s nonprofit beneficiaries. Beginning in 2017 to mark Culver City's centennial, Screenland 5K has become an [...]
Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger
05/02/2025
TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by [...]
Adia Nutrition Advances Towards OTCQB Uplisting with Third-Party Audit and Provides Roadmap to Listing on Nasdaq Small Cap
05/02/2025
WINTER PARK, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTC Pink: ADIA), an innovator nutritional products and medical treatments, has announced that through collaboration with Adia’s accountant, Adia [...]
Imprivata Enterprise Access Management Wins 2025 Best in KLAS Award for Access Management
05/02/2025
WALTHAM, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Imprivata ® , the digital identity company for life- and mission-critical industries, today announced that Imprivata Enterprise Access Management (EAM) has been named [...]
Faraday Pharmaceuticals to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
05/02/2025
SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the prevention of heart failure by reducing myocardial damage in acute ST-elevation [...]
Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners
05/02/2025
Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO and Ampersand’s deep experience in CDMO investing to support Avid’s next stage of rapid growth including [...]
Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold
05/02/2025
Teaming up to raise awareness of the continuing toll of COVID-19 in America, an ongoing mass disabling event causing an American death approximately every 9 minutes with over 59,000 deaths and 665,000 hospitalizations [...]
Accumulus Synergy Powers Industry’s First Digitally Generated Dossier to Nearly Two Dozen Countries Simultaneously
05/02/2025
BURLINGAME, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- In an industry-defining moment, Accumulus Synergy (“Accumulus”) has powered Amgen’s groundbreaking regulatory submission: the first-ever, digitally generated [...]
Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
05/02/2025
GARDEN CITY, N.Y., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
05/02/2025
WASHINGTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced [...]
FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates
05/02/2025
FibroBiologics to also present at the BIO CEO & Investor Conference HOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160 [...]
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
05/02/2025
FORT LEE, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of [...]
New Survey from Aeroflow Urology Reveals Lack of Postpartum Incontinence Care Causes Lasting Health Problems for Mothers
05/02/2025
Despite 85% of mothers experiencing frequent bladder leaks during postpartum, the survey found only 15% of mothers received resources and supplies from their providers to help manage their incontinence ASHEVILLE, N.C., [...]
Annovis Bio, Inc. Announces Closing of $21 Million Public Offering
04/02/2025
MALVERN, PA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- via IBN - Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative [...]

Pages